Ischemic heart disease Board decisions

The Board denied an increased rating for coronary artery disease and a compensable rating for hypertension, while remanding the claim for hypothyroidism.

The Board denied the veteran's claims for earlier effective dates for service connection for various conditions, including coronary artery disease and Parkinson's disease, as there was no evidence of direct or presumed exposure to herbicide agents prior to the enactment of the PACT Act on August 10, 2022.

The Board denied service connection for autoimmune arthritis and denied initial ratings in excess of 10 percent, 60 percent, and 20 percent for atrial fibrillation, coronary artery disease, and diabetes mellitus, respectively. The Board also denied an initial compensable rating for a residual scar associated with CAD and denied initial ratings in excess of 10 percent for bilateral lower extremity femoral and sciatic nerve neuropathies.

The Board denied service connection for a heart disability, to include residuals of myocardial infarction and coronary artery disease, and denied a compensable rating for pseudofolliculitis barbae. The Board also denied a rating in excess of 10 percent prior to June 5, 2023, and a rating in excess of 30 percent from June 5, 2023, for scars, neck and left cheek, associated with pseudofolliculitis barbae. However, the Board granted service connection for a left second digit scar with pain.

The Board granted service connection for coronary artery disease, atherosclerotic cardiovascular disease, valvular heart disease to include aortic atherosclerosis as secondary to posttraumatic stress disorder with major depressive disorder and bruxism based on the most probative evidence supporting a relationship between the Veteran's PTSD and his heart condition.

The Board denied the Veteran's appeal for an earlier effective date for service connection of coronary artery disease with angina, as there was no evidence of a formal claim or new and relevant evidence received prior to April 28, 2023.

The Board denied service connection for dyslipidemia and remanded the claims for coronary artery disease and liver disease due to a need for further evidence.

The Board denied the Veteran's request for restoration of a 60 percent evaluation for ischemic heart disease from November 6, 2017, and granted an earlier effective date for TDIU beginning October 9, 2015.

The Board denied service connection for the cause of the Veteran's death, as there was no evidence that any heart conditions were related to his military service.

The Veteran's service-connected ischemic heart disease was granted a 30 percent increased disability evaluation, effective May 8, 2022. Service connection for hypothyroidism and a compensable rating for hypertension were denied.

The Board remands the matter for a more adequate VA examination to address the severity of the Veteran's heart disability, including METs levels at which symptoms are experienced.

The Veteran's service-connected disabilities, including bilateral flat feet with plantar fasciitis and degenerative arthritis, have rendered him unable to secure or follow a substantially gainful occupation, entitling him to special monthly compensation at the statutory housebound rate beginning December 23, 2020.

The Board remands the claims for a rating in excess of 30 percent for ischemic heart disease and service connection for sinusitis for further evidentiary development.

The Board denied service connection for heart condition and remanded the claims for diabetes mellitus, type II and peripheral neuropathy of the right lower extremity.

The Board dismissed all claims for service connection and an increased rating due to the lack of new and relevant evidence, except for sinusitis which was not readjudicated.

The Board granted service connection for the Veteran's cause of death, as hypertension and ischemic heart disease were found to have contributed to his death. The claim for Dependency and Indemnity Compensation (DIC) under 38 U.S.C. § 1318 was denied.

The Board denied the Veteran's claim for service connection for a heart condition, to include tricuspid valvular disorder and vasovagal syncope, as there was no evidence of an in-service incurrence or aggravation of the disability.

The Board granted earlier effective dates for service connection of coronary artery disease, left lower extremity scar, and left upper extremity scar, but denied an earlier effective date for hypertension. The Board also granted a 10% rating for hypertension.

The Board denied a higher staged disability rating for coronary artery disease, granted service connection for hypertension, and granted TDIU from December 27, 2017.

The Board remands the claims for service connection for a colon disorder and heart disorder due to concerns about the adequacy of the toxic exposure risk activity memorandum.